Provided by Tiger Trade Technology Pte. Ltd.

Celldex Therapeutics

40.57
+0.19000.47%
Post-market: 40.570.00000.00%16:20 EDT
Volume:416.89K
Turnover:16.90M
Market Cap:3.18B
PE:-9.35
High:40.98
Open:40.16
Low:39.53
Close:40.38
52wk High:45.14
52wk Low:21.34
Shares:78.49M
Float Shares:73.02M
Volume Ratio:0.43
T/O Rate:0.57%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.3401
EPS(LYR):-3.9000
ROE:-43.88%
ROA:-27.62%
PB:4.46
PE(LYR):-10.40

Loading ...

Celldex Posts Investor Presentation Highlighting Barzolvolimab Late-Stage Chronic Urticaria Program Milestones

Reuters
·
Aug 15

Celldex Therapeutics (CLDX) Reported Wider Losses, Is It Still Undervalued?

Simply Wall St.
·
Aug 12

Celldex (CLDX) Gets a Buy from Jefferies

TIPRANKS
·
Aug 08

Celldex Therapeutics is Maintained at Overweight by Morgan Stanley

Dow Jones
·
Aug 08

Analysts Offer Insights on Healthcare Companies: Zoetis (ZTS) and Celldex (CLDX)

TIPRANKS
·
Aug 08

Celldex price target raised to $46 from $40 at Morgan Stanley

TIPRANKS
·
Aug 07

Celldex Therapeutics Q2 EPS $(0.94) Beats $(1.07) Estimate, Sales $22.000K Miss $954.444K Estimate

Benzinga Earnings
·
Aug 07

Celldex Therapeutics, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Celldex Q2 FY26 Net Loss Widens to $73.5 Million; R&D Expenses Climb to $67.5 Million

Reuters
·
Aug 07

Celldex Therapeutics Q2 Revenue USD 22 Thousand

THOMSON REUTERS
·
Aug 07

Celldex Therapeutics (CLDX) After Phase 2 Trial Results As Valuation Questions Come Into Focus

Simply Wall St.
·
Aug 01

PharmaCyte Net Loss Widens to $19.42 Million in FY26; Revenue Remains no Revenue

Reuters
·
Jul 30

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Celldex (CLDX)

TIPRANKS
·
Jul 25

U.S. Stocks on the Move-ge Vernova, Arrowhead Pharma

Reuters
·
Jul 22

Celldex Therapeutics Shares Down 2.6% After Scrapping Development of Skin Disease Drug

THOMSON REUTERS
·
Jul 22

Analysts Are Bullish on Top Healthcare Stocks: Vanda (VNDA), Celldex (CLDX)

TIPRANKS
·
Jul 22

Celldex price target lowered to $61 from $67 at Cantor Fitzgerald

TIPRANKS
·
Jul 22

Celldex Therapeutics is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Jul 22

Wells Fargo Keeps Their Buy Rating on Celldex (CLDX)

TIPRANKS
·
Jul 22